Clinical trial
Randomized Controlled Clinical Study to Compare the Efficacy and Safety of Different Dose of Tirofiban in Interventional Treatment of Complex Coronary Artery Disease
NCT02294994 is registered in ClinicalTrials.gov with Second Hospital of Jilin University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Controlled Clinical Study to Compare the Efficacy and Safety of Different Dose of Tirofiban in Interventional Treatment of Complex Coronary Artery Disease
- Lead sponsor
- Second Hospital of Jilin University
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- November 30, 2014
- Completion date
- December 31, 2016
- Enrollment
- 1,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.